David Carter is a seasoned scientist with extensive experience in drug discovery and biophysical analysis. Currently serving as a Senior Scientist I at Generate:Biomedicines, David utilizes high throughput biophysical screening technologies to facilitate machine learning-driven drug discovery. Previous roles include leading drug discovery and platform development programs at Agenus, and serving as Group Leader for Biophysical Analysis at Pure Biologics S.A., where expertise in biophysics and structural biology was applied to support therapeutic development. David's academic background includes a Ph.D. in Microbiology and Immunology from McGill University and a Master’s in Biochemistry from Concordia University.
Sign up to view 0 direct reports
Get started